276 related articles for article (PubMed ID: 27624579)
1. Islet amyloid polypeptide response to maximal hyperglycemia and arginine is altered in impaired glucose tolerance and type 2 diabetes mellitus.
Guardado-Mendoza R; Chávez AO; Jiménez-Ceja LM; Hansis-Diarte A; DeFronzo RA; Folli F; Tripathy D
Acta Diabetol; 2017 Jan; 54(1):53-61. PubMed ID: 27624579
[TBL] [Abstract][Full Text] [Related]
2. Islet amyloid polypeptide (IAPP) secretion from islet cells and its plasma concentration in patients with non-insulin-dependent diabetes mellitus.
Hanabusa T; Kubo K; Oki C; Nakano Y; Okai K; Sanke T; Nanjo K
Diabetes Res Clin Pract; 1992 Jan; 15(1):89-96. PubMed ID: 1541240
[TBL] [Abstract][Full Text] [Related]
3. Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus.
Enoki S; Mitsukawa T; Takemura J; Nakazato M; Aburaya J; Toshimori H; Matsukara S
Diabetes Res Clin Pract; 1992 Jan; 15(1):97-102. PubMed ID: 1541241
[TBL] [Abstract][Full Text] [Related]
4. Pathogenetic mechanisms of impaired glucose tolerance and type II diabetes in African-Americans. The significance of insulin secretion, insulin sensitivity, and glucose effectiveness.
Osei K; Gaillard T; Schuster DP
Diabetes Care; 1997 Mar; 20(3):396-404. PubMed ID: 9051394
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of total and nonglycosylated amylin in plasma characterizes subjects with impaired glucose tolerance and type 2 diabetes.
Mäkimattila S; Fineman MS; Yki-Järvinen H
J Clin Endocrinol Metab; 2000 Aug; 85(8):2822-7. PubMed ID: 10946889
[TBL] [Abstract][Full Text] [Related]
6. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
[TBL] [Abstract][Full Text] [Related]
7. Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.
Kahn SE; Verchere CB; Andrikopoulos S; Asberry PJ; Leonetti DL; Wahl PW; Boyko EJ; Schwartz RS; Newell-Morris L; Fujimoto WY
Diabetes; 1998 Apr; 47(4):640-5. PubMed ID: 9568698
[TBL] [Abstract][Full Text] [Related]
8. Parallel changes of proinsulin and islet amyloid polypeptide in glucose intolerance.
MacNamara CM; Barrow BA; Manley SE; Levy JC; Clark A; Turner RC
Diabetes Res Clin Pract; 2000 Oct; 50(2):117-26. PubMed ID: 10960722
[TBL] [Abstract][Full Text] [Related]
9. Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with a pro-atherogenic lipid profile.
Andreozzi F; Mannino GC; Perticone M; Perticone F; Sesti G
Atherosclerosis; 2017 Jan; 256():15-20. PubMed ID: 27940375
[TBL] [Abstract][Full Text] [Related]
10. Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes.
Kautzky-Willer A; Thomaseth K; Ludvik B; Nowotny P; Rabensteiner D; Waldhäusl W; Pacini G; Prager R
Diabetes; 1997 Apr; 46(4):607-14. PubMed ID: 9075800
[TBL] [Abstract][Full Text] [Related]
11. In vivo insulin sensitivity and secretion in obese youth: what are the differences between normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes?
Bacha F; Gungor N; Lee S; Arslanian SA
Diabetes Care; 2009 Jan; 32(1):100-5. PubMed ID: 18835946
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients.
Miyazaki Y; Pipek R; Mandarino LJ; DeFronzo RA
Int J Obes Relat Metab Disord; 2003 Jan; 27(1):88-94. PubMed ID: 12532159
[TBL] [Abstract][Full Text] [Related]
13. Evidence against a rate-limiting role of proinsulin processing for maximal insulin secretion in subjects with impaired glucose tolerance and beta-cell dysfunction.
Stumvoll M; Fritsche A; Stefan N; Hardt E; Häring H
J Clin Endocrinol Metab; 2001 Mar; 86(3):1235-9. PubMed ID: 11238514
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of non-glucose versus glucose stimulation test in estimating islet β-cell function in individuals with differential glucose tolerance].
He Y; Wang C; Li F; Gheng H; Yan L
Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(10):760-3. PubMed ID: 23755814
[TBL] [Abstract][Full Text] [Related]
15. [Application of hyperglycemic clamp technique in the assessment of beta-cell function in obese individuals with glucose intolerance].
Bao YQ; Jia WP; Zhu M; Lu JX; Chen L; Xiang KS
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1781-4. PubMed ID: 15631773
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of proamylin and amylin in normal subjects and patients with impaired glucose regulation and type 2 diabetes mellitus.
Zheng X; Ren W; Zhang S; Liu J; Li S; Li J; Yang P; He J; Su S; Li P
Acta Diabetol; 2010 Sep; 47(3):265-70. PubMed ID: 20509034
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of beta-cell dysfunction of impaired glucose tolerance: evidence for impairment of incretin-induced insulin secretion.
Fritsche A; Stefan N; Hardt E; Häring H; Stumvoll M
Diabetologia; 2000 Jul; 43(7):852-8. PubMed ID: 10952457
[TBL] [Abstract][Full Text] [Related]
18. Decrease of stimulated amylin release precedes impairment of insulin secretion in type II diabetes.
Ludvik B; Lell B; Hartter E; Schnack C; Prager R
Diabetes; 1991 Dec; 40(12):1615-9. PubMed ID: 1756902
[TBL] [Abstract][Full Text] [Related]
19. Xenin-25 amplifies GIP-mediated insulin secretion in humans with normal and impaired glucose tolerance but not type 2 diabetes.
Wice BM; Reeds DN; Tran HD; Crimmins DL; Patterson BW; Dunai J; Wallendorf MJ; Ladenson JH; Villareal DT; Polonsky KS
Diabetes; 2012 Jul; 61(7):1793-800. PubMed ID: 22522617
[TBL] [Abstract][Full Text] [Related]
20. Effect of Mild Physiologic Hyperglycemia on Insulin Secretion, Insulin Clearance, and Insulin Sensitivity in Healthy Glucose-Tolerant Subjects.
Merovci A; Tripathy D; Chen X; Valdez I; Abdul-Ghani M; Solis-Herrera C; Gastaldelli A; DeFronzo RA
Diabetes; 2021 Jan; 70(1):204-213. PubMed ID: 33033064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]